Type:

Fundraising update from Anaphylaxis UK 11th January 2023

As we kick start another exciting year, we want to let you know about all the fundraising updates taking place at Anaphylaxis UK.

Read more
Anaphylaxis UK ambassador Julianne Ponan receives MBE 3rd January 2023

Anaphylaxis UK would like to congratulate Julianne Ponan, entrepreneur and allergy advocate, on receiving an MBE for her service to business, exports, and people with allergies.

Read more
Taking part in Veganuary? Advice for those with food allergies  21st December 2022

If you are taking part in Veganuary this month and have a food allergy, it’s important to understand the difference between a food labelled vegan or plant-based and an ‘allergen-free’ claim.

Read more
Palforzia® not recommended for use within NHSScotland 15th December 2022

The Scottish Medicines Consortium (SMC) has completed its assessment of Arachis hypogaea L., semen (peanuts) (Palforzia®),and have confirmed this is not recommended for use within NHSScotland. They concluded that  treatment with Palforzia® is expected to be resource intensive with food allergy

Read more
North Yorkshire restaurant fined £2.5k after peanut protein was found in “peanut-free” curry 13th December 2022

A restaurant owner in North Yorkshire has been fined for selling a curry that could have caused anaphylaxis if eaten by someone with a peanut allergy.

Read more
Prevention of Future of Death report following Celia Marsh inquest  7th December 2022

Following the conclusion of the inquest into the death of Celia Marsh, the coroner has issued a Prevention of Future Deaths Report. 

Read more
Celebrating Christmas, Hanukkah, Yule or other winter festivals? Keep a look out for these allergens 28th November 2022

If you or your child live with a serious allergy, the festive period can be challenging. With much of the celebrations centred around food, allergens can find their way into a variety of products.  Here’s a list of festive food

Read more
In memory of Frans Timmermans 23rd November 2022

Anaphylaxis UK is deeply saddened to learn of the death of Frans Timmermans, founder of the Dutch Anaphylaxis Network.

Read more
Positive results from study of Palforzia in peanut-allergic children aged 1 to 3  15th November 2022

Aimmune Therapeutics has shared its positive findings from the Phase 3 POSEIDON study of Palforzia.  

Read more